About Tru Niagen

Developed by ChromaDex, a pioneer in NAD+ and healthy-aging research, Tru Niagen® is the number one NAD+ brand in the United States.³

Helping people around the world transform the way they age, Tru Niagen is clinically proven to increase NAD+ levels and help sustain them over time. It’s powered by our patented form of nicotinamide riboside, Niagen®, the most well-researched, quality-tested, efficient NAD+ precursor available. Explore our groundbreaking clinical research.

We set the gold standard in scientific rigor, safety, quality, and transparency. Backed by two Nobel Prize winners, 35+ human clinical studies, and 400+ published scientific studies, and has been accepted by the world’s most rigorous regulatory bodies.

We want to get the most out of every moment. Our purpose is to invigorate life, even through challenging times.

A legacy of innovation and discovery

  • 1999

    A vision is born

    ChromaDex is founded with a bold mission: to bring cutting-edge science to the world. Collaborating with top universities and institutions, we set the stage for life-changing health innovations.

  • 2005

    Science takes center stage

    We begin licensing groundbreaking ingredient technologies. This pivotal moment drives our ambition to unlock new possibilities in human health through science

  • 2013

    Introducing Niagen

    ChromaDex makes waves with Niagen, a patented form of Nicotinamide Riboside (NR). This revolutionary discovery redefines cellular health and aging, bringing us closer to healthier lives.

  • 2016

    The Launch of Tru Niagen

    With Tru Niagen, our vision becomes reality. Consumers around the world can now support their cellular health through this innovative product, marking a new era for ChromaDex.

  • 2020

    Global expansion

    Tru Niagen expands internationally, cementing ChromaDex as a leader in health and wellness. Our evidence-based approach earns global recognition and trust.

  • Today

    Setting the standard

    Tru Niagen sets the industry standard for safety, quality, and transparency. Backed by two Nobel Prize winners, 30+ clinical trials, and 400+ studies, it’s recognized by leading regulatory authorities. And we’re just getting started—ChromaDex is committed to driving the future of health through innovation.

Setting the gold standard in the supplement industry since 1999.

ChromaDex represents 25 years of world-leading scientific innovation and excellence. Tru Niagen is backed by Nobel prize-winning scientists, 35+ published peer-reviewed human clinical studies, 400+ published studies, and regulatory acceptance by the four most rigorous regulatory bodies in the world: the U.S., Canada, the European Union, and Australia.

Backed by world-leading scientists

Truovix, powered by ChromaDex, leverages 25 years of scientific excellence. Our foundation is solidified by an esteemed scientific advisory board, including Nobel Prize laureates Sir John Walker (Cambridge) and Dr. Roger Kornberg (Stanford).

Our Chief Scientific Advisor is Dr. Charles Brenner, a world-leading pioneer in NAD+ research, who discovered the NAD-boosting potential of our star ingredient, NR. Our commitment to cutting-edge research and innovation drives our mission to enhance health and longevity.

  • Dr. Charles Brenner

    Chair of the Department of Diabetes and Cancer Metabolism, City of Hope

    World's foremost authority on NAD+ metabolism

  • Dr. Vilhelm (Will) Bohr, M.D., Ph.D., D.Sc.

    Chief of the Laboratory of Molecular Genetics at the National Institute on Aging

    One of the world’s most published researchers on aging and neurodegenerative disease

  • Dr. Roger Kornberg

    Professor of Structural Biology, Stanford University School of Medicine

    Nobel Prize Winner, Chemistry

  • Dr. Rudolph Tanzi

    Kennedy Professor of Neurology, Harvard University

    Director, Genetics and Aging Research Unit, Massachusetts General Hospital

Our dedication to scientific research

We value and encourage strong scientific rigor and evidence behind our claims. We have a dedicated state-of-the-art research and development facility in Longmont, Colorado. Our science is global with more than 300 research collaborations through the ChromaDex External Research Program (CERP).